iCoreConnect to resell iCoreRx cloud eprescribing solution by iCoreConnect
| ICCT Stock | USD 2.44 0.22 8.27% |
Slightly above 61% of ICoreConnect Common's investor base is looking to short. The analysis of the overall investor sentiment regarding iCoreConnect Common stock suggests that many traders are alarmed. ICoreConnect Common's investing sentiment can be driven by a variety of factors including economic data, ICoreConnect Common's earnings reports, geopolitical events, and overall market trends.
ICoreConnect |
iCoreConnect has announced a new reseller agreement with mConsent, a leader in digital patient intake, patient communication and engagement solutions. Th
Read at seekingalpha.com
 |
ICoreConnect Common Fundamental Analysis
We analyze ICoreConnect Common's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of ICoreConnect Common using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of ICoreConnect Common based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Price To Book
Price To Book Comparative Analysis
ICoreConnect Common is currently under evaluation in price to book category among its peers. Price to Book (P/B) ratio is used to relate a company book value to its current market price. A high P/B ratio indicates that investors expect executives to generate more returns on their investments from a given set of assets. Book value is the accounting value of assets minus liabilities.
iCoreConnect Common stock Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with ICoreConnect Common stock to make a market-neutral strategy. Peer analysis of ICoreConnect Common could also be used in its relative valuation, which is a method of valuing ICoreConnect Common by comparing valuation metrics with similar companies.
Peers
ICoreConnect Common Related Equities
| EVAHF | EGF Theramed | 20.00 | ||||
| SY | So Young | 9.30 | ||||
| MITI | Mitesco | 8.70 | ||||
| HITC | Healthcare Integrated | 6.67 | ||||
| EVH | Evolent Health | 5.35 | ||||
| COGZF | Cogstate | 1.59 | ||||
| WORX | Scworx Corp | 9.63 |
Additional Tools for ICoreConnect Stock Analysis
When running ICoreConnect Common's price analysis, check to measure ICoreConnect Common's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy ICoreConnect Common is operating at the current time. Most of ICoreConnect Common's value examination focuses on studying past and present price action to predict the probability of ICoreConnect Common's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move ICoreConnect Common's price. Additionally, you may evaluate how the addition of ICoreConnect Common to your portfolios can decrease your overall portfolio volatility.